Dianthus Therapeutics (DNTH) Misses Q1 EPS by 82c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q1 EPS of ($0.82). Revenue for the quarter came in at $1.16 million.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Sangamo files Chapter 11, agrees to sell assets to Lilly, Astellas
• Peer To Peer Network (OTC:PTOP) Unveils MOBICARD 1.9, Introducing Networking Mode and Smart Follow-Up - A First-of-Its-Kind Intelligent Relationship-Building Platform